Celltrion Pharm Inc (068760.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · South Korea · ISIN KR7068760008
Celltrion Pharm Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 477.84 bn KRW | 536.40 bn KRW |
| Gross profit | 122.01 bn KRW | 163.78 bn KRW |
| Operating income | 37.22 bn KRW | 56.09 bn KRW |
| EBIT | 37.26 bn KRW | 56.38 bn KRW |
| Net income | 21.97 bn KRW | 38.75 bn KRW |
| Diluted EPS – continuing operations | 505.39 KRW | 874.86 KRW |
Full history since 2006, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Celltrion Pharm Inc
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.
More stocks
- Ziel Home Furnishing Technology Co. Ltd. A (301376.SZ)
- Amprius Technologies, Inc. (AMPX)
- Patria Private Equity Trust PLC (PPET.L)
- Eramet SA (ERA.PA)
- Aryzta AG (ARYN.SW)
- BKI HOLDINGS PUBLIC COMPANY LIMITED (BKIH.BK)
- Ivanhoe Energy Inc (IE.TO)
- Baltic Classifieds Group PLC (BCG.L)
- Shanghai OPM Biosciences Co. Ltd. A (688293.SS)
- Domino's Pizza Group PLC (DOM.L)
- TR Property Investment Trust PLC (TRY.L)
- Poongsan (103140.KS)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.